|
Available-For-Sale-Investments - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified |
Sep. 30, 2013
|
Jun. 30, 2013
|
|---|---|---|
| Schedule of Available-for-sale Securities [Line Items] | ||
| Available-for-sale securities, fair value | $ 239.0 | $ 302.0 |
| Available-for-sale securities, amortized cost | 233.0 | 241.0 |
|
Chemo Centryx, Inc.
|
||
| Schedule of Available-for-sale Securities [Line Items] | ||
| Available-for-sale securities, fair value | 35.2 | 89.6 |
| Available-for-sale securities, amortized cost | $ 29.5 | $ 29.5 |
| X | ||||||||||
|
- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|